At the recently held Korean Society for Laboratory Medicine’s 2023 spring symposium, Siemens Healthineers AG has launched Atellica CI 1900 Analyzer  in South Korea. The integrated biochemical and immunoassay solution is expected to contribute to the growth of the integrated clinical chemistry and immunochemistry analyzers market in South Korea, says GlobalData, a leading data and analytics company.

As the demand for testing increases, laboratory automation is transforming the medical laboratory space and is gradually replacing manual and semi-automated methods.

Against this backdrop, GlobalData’s Clinical Chemistry Analyzers Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2033 report reveals that the integrated clinical chemistry and immunochemistry analyzer market holds the largest market share, accounting for approximately 60% of the Korean clinical chemistry analyzers market and is expected to grow rapidly.

Damini Goyal, Medical Devices Analyst at GlobalData, comments: “Compared to individual analyzers, integrated analyzers reduce turnaround time by providing a single platform that uses advanced technology to run a wide range of assays simultaneously. Lab workflow is streamlined with automated sample management and a command-and-control interface, allowing medical staff to focus more on results and productivity.”

Atellica CI 1900 Analyzer received approval from the Ministry of Food and Drug Safety in March. It can process up to 1,120 tests per hour (1,000 biochemical tests, 120 immunoassays, and STAT sample processing in less than 1 minute). The device is also supported by integrated multi-sensor technology and micro-volume technology, providing a magnified view and real-time monitoring of electrolytes present in blood, plasma, and urine samples.

Goyal concludes: “The market for integrated clinical chemistry analyzers is expected to increase as these systems offer the benefit of consolidation, eliminating the need for separate quality control, preventive maintenance, and record keeping for multiple analyzers. Reliable results, safe working conditions, increased productivity, significant savings in time, space and cost are just some of the main advantages of these devices. With the increasing demand for laboratory automation and their continued use in routine diagnostics, the market is poised for steady growth and significant growth opportunities.”